HepaRegeniX GmbH

1 trials Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

3 Countries active

1 Unique IMPs

N/A Results reported

Phase I/II

Top IMPs

DARIZMETINIB HYDROCHLORIDE 1

All trials

1 total

Study to assess how safe and effective is HRX215 in participants who underwent minor and major liver surgery due to colon carcinoma metastas… Pending

2025-523630-59-00 Phase I/II 3 countries DARIZMETINIB HYDROCHLORIDE

Showing 1–1 of 1 trials

← All sponsors A–Z